Quercetin changes purinergic enzyme activities and oxidative profile in platelets of rats with hypothyroidism

Biomed Pharmacother. 2016 Dec:84:1849-1857. doi: 10.1016/j.biopha.2016.10.109. Epub 2016 Nov 7.

Abstract

Diseases related to thyroid hormones have been extensively studied because affect a large number of individuals, and these hormones participate in the regulation of the whole organism homeostasis. However, little is known about the involvement of purinergic signaling related to oxidative stress in hypothyroidism and possible therapeutic adjuncts for treatment of this disorder. Thus, the present study investigates the effects of quercetin on NTPDase, 5'-nucleotidase and adenosine deaminase activities, platelet aggregation and oxidative profile in platelets of rats with methimazole (MMI)-induced hypothyroidism. Methimazole at a concentration of 20mg/100mL was administered for 90days. From the second month the animals received quercetin 10 or 25mg/kg for 60days. Results showed that: Ecto-5'-nucleotidase activity decreased in methimazole/water group and the treatment with quercetin 25mg/kg decreased NTPDase, 5'-nucleotidase and adenosine deaminase activities. Moreover, platelet aggregation increased in methimazole/water group. Lipid peroxidation increased while superoxide dismutase and catalase activities decreased, but, interestingly, the treatment with quercetin reversed these changes. These results demonstrated that quercetin modulates adenine nucleotide hydrolysis decreasing the ADP formation and adenosine deamination. At the same time quercetin improves the oxidative profile, as well as reduces platelet aggregation, which together with the modulation in the nucleotides levels can contribute to the prevention of platelet disorders.

Keywords: Ectonucleotidases; Hypothyroidism; Oxidative stress; Platelet aggregation; Quercetin.

MeSH terms

  • Adenine Nucleotides / blood
  • Adenosine Deaminase / blood*
  • Animals
  • Antioxidants / pharmacology*
  • Blood Platelets / drug effects*
  • Blood Platelets / enzymology
  • Catalase / blood
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Hydrolysis
  • Hypothyroidism / blood
  • Hypothyroidism / chemically induced
  • Hypothyroidism / drug therapy*
  • Hypothyroidism / enzymology
  • Kinetics
  • Lipid Peroxidation / drug effects
  • Male
  • Membrane Proteins / blood
  • Methimazole
  • Oncogene Proteins / blood*
  • Oxidative Stress / drug effects*
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / pharmacology*
  • Quercetin / pharmacology*
  • Rats, Wistar
  • Superoxide Dismutase / blood

Substances

  • Adenine Nucleotides
  • Antioxidants
  • Entpd5 protein, rat
  • Membrane Proteins
  • Oncogene Proteins
  • Platelet Aggregation Inhibitors
  • Methimazole
  • Quercetin
  • Catalase
  • Superoxide Dismutase
  • Ada protein, rat
  • Adenosine Deaminase